These results suggest that patients on rFVIIIFc prophylaxis can reduce their infusion frequency as compared with their prior FVIII regimen while maintaining low bleeding rates , affording more patients trough levels of 1 IU dL ( -1 ) than with rFVIII products requiring more frequent dosing regimens .